Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-059907 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
113,055
Total Value
$6,860,681.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 1, 2026 | Sale to Issuer | 13,300 | $85.00 | $1,130,500.00 | 5,925 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale to Issuer | 5,925 | $85.00 | $503,625.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 35,000 | $56.69 | $1,984,150.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 8,750 | $66.71 | $583,712.50 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 17,500 | $64.68 | $1,131,900.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 12,500 | $40.29 | $503,625.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 10,350 | $52.67 | $545,134.50 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 9,730 | $49.13 | $478,034.90 | 0 | Direct | โ | View Details |